QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.105.084541v1 313/3/1223    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, S.-M. Articles by Katz, J. L. Search for Related Content PubMed PubMed Citation Articles by Li, S.-M. Articles by Katz, J. L.

BEHAVIORAL PHARMACOLOGY

Place Conditioning and Locomotor Effects of N-Substituted, 4',4''-Difluorobenztropine Analogs in Rats

Psychobiology (S.-M.L., J.L.K.) and Medicinal Chemistry (A.H.N.) Sections, Medications Discovery Research Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, Maryland

Previous studies demonstrated that analogs of benztropine [3-(diphenyl-methoxy)tropane (BZT)] bind to the dopamine (DA) transporter with high affinity, inhibit DA uptake, but do not maintain rates of responding in self-administration procedures comparable with those maintained by cocaine. Some BZT analogs have an onset of action that is slower than that for cocaine that may contribute to this decreased effectiveness. In addition, some BZT analogs have affinity for muscarinic-M1 receptors that may interfere with reinforcing effects. The present study assessed effects of BZT analogs in place-conditioning procedures designed to accommodate variations in onset of effect. BZT analogs with variations in relative affinities for the DA transporter over M1 receptors from equal [AHN 1-055 (3-[bis(4'-fluorophenyl)methoxy]-tropane)] to 16-fold [JHW 007 (N-(n-butyl)-3-[bis(4'-fluorophenyl)methoxy]-tropane)] were compared with cocaine and the muscarinic antagonist, atropine. Cocaine (10–20 mg/kg) but not atropine (1.0–5.6 mg/kg) produced dose-related place conditioning. The N-methyl-substituted BZT analog, AHN 1-055, was without significant effects at doses that ranged from 0.3 to 3.0 mg/kg and when administered up to 90 min before conditioning trials. In contrast, effects of AHN 2-005 (N-allyl-3-[bis(4'-fluorophenyl)methoxy]-tropane; 0.1–10.0 mg/kg) were significant, and those of JHW 007 approached significance when administered 45 min but not immediately or 90 min before trials. Atropine blocked the effect of AHN 2-005 and approached significant antagonism of cocaine. The present study further supports and extends previous results showing minimal preclinical indications of abuse liability of BZT analogs and suggests that these differences from cocaine are not entirely accounted for by a slower onset of action or muscarinic M1 receptor affinity.

Address correspondence to: Dr. Jonathan L. Katz, National Institute on Drug Abuse, Intramural Research Program, 5500 Nathan Shock Drive, Baltimore, MD 21224. E-mail: jkatz{at}intra.nida.nih.gov

This article has been cited by other articles:

				T. Hiranita, P. L. Soto, A. H. Newman, and J. L. Katz Assessment of Reinforcing Effects of Benztropine Analogs and Their Effects on Cocaine Self-Administration in Rats: Comparisons with Monoamine Uptake Inhibitors J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 677 - 686. [Abstract] [Full Text] [PDF]

				G. Tanda, A. L. Ebbs, T. A. Kopajtic, L. M. Elias, B. L. Campbell, A. H. Newman, and J. L. Katz Effects of Muscarinic M1 Receptor Blockade on Cocaine-Induced Elevations of Brain Dopamine Levels and Locomotor Behavior in Rats J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 334 - 344. [Abstract] [Full Text] [PDF]

				A. A. Othman, S. A. Syed, A. H. Newman, and N. D. Eddington Transport, Metabolism, and in Vivo Population Pharmacokinetics of the Chloro Benztropine Analogs, a Class of Compounds Extensively Evaluated in Animal Models of Drug Abuse J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 344 - 353. [Abstract] [Full Text] [PDF]